BGLAP and metabolic syndrome: P1NP (31.2 ng/ml, 95% CI: 27.1; 35.4 vs. 41.8 ng/ml, 95% CI: 37.5; 46.2) and osteocalcin (13.0 ng/ml, 95% CI: 11.0; 14.9 vs. 19.3 ng/ml, 95% CI: 17.8; 20.9) levels were lower among individuals with T2D compared to MetS, also after adjustment for age, BMI, and smoking.